Determining the Effectiveness of Acceptance and Commitment-Based Therapy on Stress, Cognitive Attentional Syndrome, and Glycosylated Hemoglobin in Type 2 Diabetic Patients

Ahmadi, Sadegh; Hamel, Omolbanin; Zarinpeikar, Arsalan; Rafiei Goligani, Samira

Volume 13 - Articles-1402 MEJDS (2023) 13: 73 | Back to browse issues page

Mendeley

Zotero

RefWorks

Ahmadi S, Hamel O, Zarinpeikar A, Rafiei Goligani S. Determining the Effectiveness of Acceptance and Commitment-Based Therapy on Stress, Cognitive Attentional Syndrome, and Glycosylated Hemoglobin in Type 2 Diabetic Patients. MEJDS 2023; 13 :73-73
URL: http://jdisabilstud.org/article-1-2165-en.html

Determining the Effectiveness of Acceptance and Commitment-Based Therapy on Stress, Cognitive Attentional Syndrome, and Glycosylated Hemoglobin in Type 2 Diabetic Patients

Sadegh Ahmadi¹

, Omolbanin Hamel ^*²

, Arsalan Zarinpeikar³

, Samira Rafiei Goligani²

1- BA in Educational Sciences, Faculty of Psychology and Educational Sciences, Farhangian University, Zanjan, Iran
2- MA Student in Clinical Psychology, Faculty of Psychology and Educational Sciences, Islamic Azad University, Shiraz, Iran
3- BA in Counseling, Faculty of Psychology and Educational Sciences, Farhangian University, Rey, Iran

Abstract: (1447 Views)

Abstract
Background & Objective: The progression of complications and high costs of diabetes treatment in these patients is mainly due to inadequate blood sugar control. So, one of the most important goals in treating these patients is to achieve proper blood sugar control; an important indicator of this control is glycosylated hemoglobin (HBA1c). The best goal in controlling and treating diabetes is to keep this index within the normal range. People with diabetes have stress and anxiety in social interactions due to constant life changes, fear of high blood sugar, and understanding how they differ from others. Their main problem is fear of what others think of them. As a result, they may avoid many social situations. Psychological stress in people with diabetes can initiate or exacerbate hyperglycemia by activating the pituitary–adrenal axis. On the other hand, one of the most essential factors in the emergence and persistence of mental disorders in victims is the content and thought style of people. From the metacognitive perspective, a mental disorder is caused by activating a specific thought style and poisoning, which is cognitive–attention syndrome. Cognitive Attentional Syndrome is defined as a repetitive thinking style that manifests itself in the form of rumination, threatening attention, and dysfunctional coping behaviors. Patients with type 2 diabetes face many problems, so using effective treatment methods to improve the psychological characteristics of these patients is essential. In this regard, one of the effective treatment methods to improve psychological characteristics that many researchers have recently considered is acceptance commitment therapy. This type of treatment is one of the third–wave behavioral therapies that emphasizes comprehensive awareness, along with openness and acceptance of pain. Diabetes is the most common disease caused by metabolic disorders that are associated with long–term complications; the burden of this disease is increasing in the world, especially in developing countries. Therefore, it has become one of the public health concerns in the 21^st century, and every year, a lot of money is spent on diabetes treatment and complications of diabetes. Thus, there is a need for new studies for its prevention and treatment. Given the prevalence of this disease in society and its complications, timely intervention is essential to reduce mental health problems and consequently improve self–management and blood sugar control. On the other hand, few studies on the relationship between stress and blood sugar control (HbA1c). Considering the role of acceptance and commitment therapy in treating diabetes in the country, research in this area is not sufficient and coherent, and different dimensions of this issue have not been well studied. To our knowledge, no direct study has been done on the effectiveness of acceptance and commitment therapy on Cognitive Attentional Syndrome in type 2 diabetic patients by considering glycosylated hemoglobin.
Methods: This quasi–experimental research employed a pretest–posttest design with a control group. The study population included all people with type 2 diabetes who were referred to Hajiabad Zirkuh Health Center, Hajiabad Zirkuh, Iran, in the fall of 2020. A total of 30 eligible people who volunteered to participate in the study were included in the study and then randomly divided into two groups: experimental and control (each 15 patients). To collect the necessary data, the Stress Anxiety Scale (Lovibond and Lovibond,1995), Cognitive Attentional Syndrome (Wells, 2009), and glycosylated hemoglobin test with autoanalyzer were used in the pretest and posttest. Then, Hayes et al.'s (2011) acceptance and commitment–based treatment was performed in 8 sessions of 90 minutes only for the experimental group, and the control group did not participate in the training. Data were analyzed with multivariate analysis of covariance using SPSS software version 24 at the significance level of α=0.01.
Results: The results showed that after adjusting the pretest scores, the mean scores of stress, cognitive attentional syndrome, and glycosylated hemoglobin in the experimental group were significantly reduced compared to the control group (p<0.001).
Conclusion: Based on the findings, acceptance and commitment–based therapy reduced stress, cognitive attentional syndrome, and glycosylated hemoglobin in patients with type 2 diabetes.

Keywords: Acceptance and commitment, Stress, Cognitive attentional syndrome, Glycosylated hemoglobin, Diabetes

Full-Text [PDF 752 kb] (267 Downloads)

Type of Study: Original Research Article | Subject: Psychology

References

1. Heltberg A, Andersen JS, Sandholdt H, Siersma V, Kragstrup J, Ellervik C. Predictors of undiagnosed prevalent type 2 diabetes – The danish general suburban population study. Prim Care Diabetes. 2018;12(1):13–22. [DOI]

2. Yousefian Z, Amin Nasab A, Sehatti M. Effectiveness of positivist psychotherapy on resilience, mental happiness and hardiness in the mothers suffering from type 2 diabetes. Family Pathology, Counseling & Enrichment. 2019; 5(1):1–16. [Persian] [Article]

3. Ong KL, Morris MJ, McClelland RL, Maniam J, Allison MA, Rye KA. Lipids, lipoprotein distribution and depressive symptoms: the multi-ethnic study of atherosclerosis. Transl Psychiatry. 2016;6(11):e962. [DOI]

4. Rhee MK, Slocum W, Ziemer DC, Culler SD, Cook CB, El-Kebbi IM, et al. Patient adherence improves glycemic control. Diabetes Educ. 2005;31(2):240–50. [DOI]

5. Ghazanfari Z, Niknami S, Ghofranipour F, Larijani B, Agha-Alinejad H, Montazeri A. Determinants of glycemic control in female diabetic patients: a study from Iran. Lipids Health Dis. 2010;9(1):83. [DOI]

6. Yu PC, Bosnyak Z, Ceriello A. The importance of glycated haemoglobin (HbA1c) and postprandial glucose (PPG) control on cardiovascular outcomes in patients with type 2 diabetes. Diabetes Res Clin Pract. 2010;89(1):1–9. [DOI]

7. Aro A, Kauppinen A, Summanen P, Kivinen N, Selander T, Kinnunen K, et al. Life style intervention improves retinopathy status—the finnish diabetes prevention study. Nutrients. 2019;11(7):1691. [DOI]

8. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752–61. [DOI]

9. Hakimi S, Simbar M, Ramezani Tehrani F. Perceived concerns of azeri menopausal women in Iran. Iran Red Crescent Med J. 2014;16(5):e11771. [DOI]

10. Elstad E, Tusiofo C, Rosen RK, McGarvey ST. Living with Ma'i Suka: individual, familial, cultural, and environmental stress among patients with type 2 diabetes mellitus and their caregivers in American Samoa. Prev Chronic Dis. 2008;5(3):A79.

11. McGrady A, Horner J. Role of mood in outcome of biofeedback assisted relaxation therapy in insulin dependent diabetes mellitus. Appl Psychophysiol Biofeedback. 1999;24(1):79–88. [DOI]

12. Sendi F, Ehteshamzadeh P, Asgari P, Kafie M. The relationship Cognitive Attentional Syndrome (CAS), with anxiety and depression in burned patients: the mediating role of coping styles. Health Psychology. 2017;6(23):74–91. [Persian] [Article]

13. Van Der Heiden C, Muris P, Van Der Molen HT. Randomized controlled trial on the effectiveness of metacognitive therapy and intolerance-of-uncertainty therapy for generalized anxiety disorder. Behav Res Ther. 2012;50(2):100–9. [DOI]

14. Wells A, Welford M, King P, Papageorgiou C, Wisely J, Mendel E. A pilot randomized trial of metacognitive therapy vs applied relaxation in the treatment of adults with generalized anxiety disorder. Behav Res Ther. 2010;48(5):429–34. [DOI]

15. Ebrahemi S, Chalabianloo G. Evaluation of the relationship between cognitive attentional syndrome with mood illusions in students. Journal of Nursing, Midwifery and Paramedical Faculty. 2019;4(3):35–43. [Persian] [Article]

16. Fergus TA, Valentiner DP, McGrath PB, Gier-Lonsway S, Jencius S. The cognitive attentional syndrome: examining relations with mood and anxiety symptoms and distinctiveness from psychological inflexibility in a clinical sample. Psychiatry Res. 2013;210(1):215–9. [DOI]

17. George RE, Joseph S. A review of newer treatment approaches for type-2 diabetes: Focusing safety and efficacy of incretin-based therapy. Saudi Pharm J. 2014;22(5):403–10. [DOI]

18. Ramsey-Wade C. Acceptance and commitment therapy: an existential approach to therapy? Existential Analysis. 2015;26(2):2–13.

19. Hayes SC. Acceptance and commitment therapy, relational frame theory, and the third wave of behavioral and cognitive therapies. Behav Ther. 2004;35(4):639–65. [DOI]

20. Lang AJ, Schnurr PP, Jain S, He F, Walser RD, Bolton E, et al. Randomized controlled trial of acceptance and commitment therapy for distress and impairment in OEF/OIF/OND veterans. Psychological Trauma: Theory, Research, Practice, and Policy. 2017;9(Suppl 1):74–84. [DOI]

21. Mousavi M, DashtBozorgi Z. Effect of acceptance and commitment group therapy (ACT) on the hardness and perceived stress coefficient among patients with type 2 diabetes. Iran J Health Educ Health Promot. 2017;5(4):311–19. [Persian] [Article]

22. Aghayosefi A, Alipour A, Rahimi M, Abaspour P. Investigation of the efficacy of acceptance and commitment therapy (ACT) on psychological indices (stress, quality of life, and coping strategies) among the patients with type II diabetes. Journal Of Isfahan Medical School. 2018;35(461):1859–66. [Persian] [DOI]

23. Shayeghian Z, Amiri P, Aguilar-Vafaie ME, Besharat MA. Effectiveness of acceptance and commitment group therapy on improvement of glaycated hemoglobin and self-care activities in patients with type II diabetes. Contemporary Psychology. 2016;10(2):41–50. [Persian] [Article]

24. Rahimi M, Nouri R, Raimi M. The effectiveness of the acceptance and commitment therapy (ACT) approach on quality of life and hemoglobin A1c among patients with type 2 diabetes. Int J Med Invest. 2019;8(2):61–9. [Persian] [Article]

25. Khashouei MM, Ghorbani M, Tabatabaei F. The effectiveness of acceptance and commitment therapy (ACT) on self-efficacy, perceived stress and resiliency in type II diabetes patients. Global Journal of Health Science. 2016;9(5):18. [DOI]

26. Darvish Baseri L, DashtBozorgi Z. Effectiveness of group therapy based on acceptance and commitment on cognitive emotion regulation and alexithymia of patients with type 2 diabetes. Iranian Journal of Psychiatric Nursing. 2017;5(1):7–14. [Persian] [DOI]

27. Zare H. Effectiveness of acceptance and commitment therapy (ACT) on improving the flexibility and cognitive fusion. Educational Sciences & Psychology. 2017;6(1):125–34. [Persian] [Article]

28. Livheim F, Hayes L, Ghaderi A, Magnusdottir T, Högfeldt A, Rowse J, et al. The effectiveness of acceptance and commitment therapy for adolescent mental health: swedish and australian pilot outcomes. J Child Fam Stud. 2015;24(4):1016–30. [DOI]

29. Zarinfar E, Balooti A, Mirzavandi J. Effect of training based on acceptance and commitment on flexibility, perceived stress and resilience of female employees of hospital. Iranian Journal of Rehabilitation Research in Nursing. 2019;5(4):26–33. [Persian] [Article]

30. Mohammad Zadeh Farhani A, Naderi F, Rajab A, Ahadi H, Kraskian A. Effectiveness of cognitive – behavioral therapy on psychological problems and Blood glucose control in children with diabetes mellitus type I. Journal of Pediatric Nursing. 2018;4(3):56–63. [Persian] [Article]

31. Delavar A. Educational and psychological research. Tehran: Virayesh Pub; 2015. [Persian]

32. Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995;33(3):335–43. [DOI]

33. Sahebi A, Asghari MJ, Salari RS. Validation of Depression Anxiety and Stress Scale (DASS-21) for an Iranian population. Journal of Developemental Psychology. 2005;1(4):36–54. [Persian] [Article]

34. Wells A, Fisher P, Myers S, Wheatley J, Patel T, Brewin CR. Metacognitive therapy in recurrent and persistent depression: a multiple-baseline study of a new treatment. Cogn Ther Res. 2009;33(3):291–300. [DOI]

35. Fergus TA, Bardeen JR, Orcutt HK. Attentional control moderates the relationship between activation of the cognitive attentional syndrome and symptoms of psychopathology. Pers Individ Dif. 2012;53(3):213–7. [DOI]

36. Farrokhi H, Sohrabi F. Investigating reliability, validity and factor structure of thePersian version of the Cognitive Attentional Syndrome (CAS-1). Analitical-Cognitive Psycholoy. 2017;8(30):9–15. [Persian]

37. Thorpe CT, Fahey LE, Johnson H, Deshpande M, Thorpe JM, Fisher EB. Facilitating healthy coping in patients with diabetes: a systematic review. Diabetes Educ. 2013;39(1):33–52. [DOI]

38. Hayes SC, Strosahl KD, Wilson K. Acceptance and commitment therapy the process and practice of mindful change. Second edition. New York, London: The Guilford Press; 2012.